• Aucun résultat trouvé

François LEFEBVRE Joins the A NOVO Group as Chief Financial Officer

N/A
N/A
Protected

Academic year: 2022

Partager "François LEFEBVRE Joins the A NOVO Group as Chief Financial Officer"

Copied!
1
0
0

Texte intégral

(1)Press Release February 13th, 2007. François LEFEBVRE Joins the A NOVO Group as Chief Financial Officer. After four years as CFO of A NOVO Group, Mireille ARVIER leaves the Company to give a new orientation to her career. The Board thanks her for her contribution in terms of restructuring and control systems implementation during these 4 years.. About A NOVO With revenues of €293,8 million and 4,700 employees, A NOVO is Europe’s leading provider of maintenance and customization services for digital products used by the major Telecommunication and Multimedia Operators in delivering Triple Play (voice/data/image) solutions. A Novo has more than 23 sites including 16 Centers of Excellence. For more information, visit our website : www.a-novo.com. Contact:. Communication :. François Lefebvre, CFO Tél. : +33 (0)1 58 17 00 81. Marc Thoumyre Tel. : +33 (0)1 58 17 00 88. ISIN Codes : FR0004152593 (actions), FR0000181174 (convertible bonds OCÉANE), FR0000341174 (ABSA), Bloomberg Code: NOVO FP ; Reuters Code : ANOV.LN. WorldReginfo - 6fe463a9-04a2-4eac-b5a3-5ba0ef10625e. François LEFEBVRE becomes Group Chief Financial Officer (Group CFO) and member of the Group Executive Committee; he brings 20 years of experience in the finance area, first as auditor at PWC, then as financial controller at VALEO and, for the past four years, as Financial Director of SFR..

(2)

Références

Documents relatifs

Pèr la Regioun PACA 797 persouno soun morto à l’espitau despièi la debuto de la pandemìo (tant coumpres residènt d’EHPAD espitalisa- do) + 289 soun morto en EHPAD tuado pèr

Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype.... Disruption of the ATP8A2 gene in a patient with

Chromosome 6q duplications have been documented repeatedly, allowing the delineation of a “6q duplication syndrome”, characterized by hypertelorism, downslanting palpebral

The synthetic protocol starting from readily available dihydronaphthalene regioisomers is based on oxidative ring olefin bond cleavage followed by ring closure of the

Positive cash flow generation Sustained profitable growth A NOVO FR0004152593 – NOV, the leading pan-European provider of after sales and customization services for

Este texto tem como principal objetivo realizar uma reaproximação com as características em um diagrama circular (Oliveira Júnior, Gargallo, Amorim e Bau, 2003) que significaram

De novo assembly and functional annotation of the transcriptome of Mimachlamys varia , a bioindicator marine bivalve... Abstract

6 INRA, Unité de Recherche en Génomique Végétale, 2 rue Gaston Crémieux, CP5708, 91057 Evry Cedex, France.. Progress in applying new methods to forest tree breeding has been